Featured
Secret Clinical Strength
Sugar Editorial Picks
Review: Secret Clinical Strength Sport Antiperspirant
Products marketed toward female athletes always pique my interest. Plus it is great to know that somebody out there knows we exist and like gear! When I saw a new antiperspirant by Secret with the word "sport" as well as the phrase "designed for athletes" on the front of the package, I was curious to try it.
Other Search Results
Omega-3 fatty acids
Overview- Overview
- Uses
- Dietary Sources
- Available Forms
- How to Take It
- Precautions
- Possible Interactions
- Supporting Research
No Sweat: Four Ways to Quit Overheating and Start Looking Hot
It's sweltering out, and no matter what you do, you are gonna get sweaty, which also means stinky. Little old Southern ladies dust on loads of scented talcum powder to absorb and deodorize body sweat, but I can't say that it's the best modern solution to the problem. Instead, I've come up with a few forward-thinking tips to help you nip the sweat monster in the bud, so keep reading.
Ovarian cancer
In This Report- Highlights
- Introduction
- Symptoms
- Causes
- Prevention
- Diagnosis
- Prognosis
- Treatment
- Surgery
- Medications
- Radiation Therapy
- Resources
- References
- Bloating
- Pelvic or abdominal pain
- Difficulty eating or feeling full quickly
- Urgent or frequent urination
- Post-menopausal women who use hormone replacement therapy (HRT) for more than 5 years are 20% more likely to develop ovarian cancer than women who do not use HRT, suggests a 2007 study in the Lancet.
Diabetes - type 2
In This Report- Highlights
- Introduction
- Causes
- Risk Factors
- Symptoms
- Screening Tests
- Treatment
- Lifestyle Changes
- Medications
- Long-Term Complications
- Emergency Complications
- Resources
- References
- Sitagliptin (Januvia), the first in a new class of diabetes drugs called DPP-4 inhibitors, was approved in 2006.
- Janumet, a 2-in-1 pill that contains both sitagliptin and metformin, was approved in 2007.
- These drugs are taken by mouth and may be more convenient for patients than exenatide (Byetta), a similar drug. DPP-4 inhibitors do not cause weight gain and may pose a lower risk for hypoglycemia than some other diabetes drugs.
Osteoarthritis
In This Report- Highlights
- Introduction
- Causes
- Symptoms
- Conditions with Similar Sym...
- Risk Factors
- Diagnosis
- Prognosis
- Lifestyle Changes
- Medications
- Alternative and Complementa...
- Surgery
- Resources
- References
- Nonsteroidal anti-inflammatory drugs (NSAIDs) and COX-2 inhibitors work equally well for pain management, but both types of drugs increase the risk for heart attacks, according to an important report from the U.S. Agency for Healthcare Quality and Research.
- The prescription NSAID diclofenac (Voltaren, Cataflam) may present a higher risk for heart attack than other NSAIDs, suggests a 2006 Journal of the American Medical Association study.
- Standard osteoarthritis medications provide moderate pain relief for only 2 - 3 weeks, suggests a 2007 review in the European Journal of Pain.
- An Annals of Internal Medicine study of 1,007 people with chronic osteoarthritis knee pain indicated that patients who received acupuncture plus standard care had greater improvement than those who received only physical therapy and anti-inflammatory drugs.
- An Arthritis and Rheumatism study of 3,663 patients with chronic osteoarthritis knee or hip pain suggested that acupuncture plus routine care can provide significant improvements in pain relief and quality of life. In both studies, the benefits of acupuncture were sustained for up to 6 months after treatment completion.
Rheumatoid arthritis
In This Report- Highlights
- Introduction
- Causes
- Risk Factors
- Symptoms
- Complications
- Diagnosis
- Treatment
- Medications
- Surgery
- Lifestyle Changes
- Resources
- References
- Patients with rheumatoid arthritis who do not respond to single-drug therapy often do better when a combination of drugs is used, indicates a review of 23 clinical trials published in 2007 in the Annals of Internal Medicine. However, the researchers were unable to determine which combinations of drugs work best or which individual drugs are more effective than others.
- Combination drug treatment is now becoming a standard approach to treating rheumatoid arthritis while it is still in its early stages. Another 2007 Annals of Internal Medicine study indicated that initial combination therapies slow progression of joint damage more rapidly than single-drug therapy but, after several years, all treatment strategies produce benefits.
Scoliosis
In This Report- Highlights
- Introduction
- Causes
- Risk Factors
- Prognosis
- Symptoms
- Diagnosis
- Treatment
- Managing Scoliosis
- Braces
- Surgery
- Treatment for Adult Scolios...
- Resources
- References
Osteoporosis
In This Report- Highlights
- Introduction
- Causes
- Symptoms
- Fractures
- Risk Factors
- Diagnosis
- Lifestyle Changes
- Medications
- Treatment
- Resources
- References
- In 2007, the Food and Drug Administration (FDA) approved zoledronic acid (Reclast) for postmenopausal osteoporosis treatment. Zoledronic acid is given as an injection once a year. A 2007 study in the New England Journal of Medicine indicated that zoledronic acid can significantly reduce the risk of spine, hip, and other fractures.
- In 2007, the FDA approved raloxifene (Evista) for prevention of breast cancer in postmenopausal women with osteoporosis and postmenopausal women at high risk for breast cancer.
Obesity
Overview- Signs and Symptoms
- What Causes It?
- Risk Factors
- Preventive Care
- What to Expect at Your Provider's Office
- Treatment Options
- Other Considerations
- Supporting Research
More on FitSugar
Fall Award Season
Top Brands
Episode
DSquared
Mustang